TrialJournal of cosmetic dermatology2025

OS-01 Peptide Topical Formulation Improves Skin Barrier Function and Reduces Systemic Inflammation Markers: A Pilot 12-Week Clinical Trial.

Alessandra Zonari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.